Pharmafile Logo

kelly smith

- PMLiVE

Eli Lilly’s Omvoh granted FDA approval to treat Crohn’s disease in adults

The drug is already approved in the US to treat ulcerative colitis, another form of inflammatory bowel disease

- PMLiVE

Novo Nordisk and Valo Health expand alliance for cardiometabolic diseases

The partners are aiming to develop new drugs for type 2 diabetes, obesity and cardiovascular disease

- PMLiVE

Santhera’s Duchenne muscular dystrophy drug Agamree accepted by SMC

The rare muscle-wasting disorder affects approximately 2,500 males in the UK at any one time

- PMLiVE

AbbVie and Simcere to advance multiple myeloma candidate in partnership worth over $1bn

SIM0500 is in phase 1 development for patients with relapsed or refractory cases of the blood cancer

Biogen Idec building

Biogen/Eisai announce FDA BLA acceptance for injectable Alzheimer’s drug

The injection process for subcutaneous Leqembi is expected to take an average of 15 seconds

regeneron headquarters

Regeneron shares positive phase 3 results for Libtayo in high-risk skin cancer

Approximately 1.8 million cases of cutaneous squamous cell carcinoma are diagnosed in the US every year

- PMLiVE

Artificial Intelligence:  How to approach the ethical cost of innovation

In a rapidly evolving industry, staying ahead means embracing new tools thoughtfully. We're setting the gold standard by ethically leveraging AI to drive innovation while ensuring patient trust and regulatory...

Mednet

- PMLiVE

How can we navigate the tension between scientific rigor and emotional resonance in brand storytelling?

In her first Ask Alex article of the year, Scientific Director, Dr Alexandra Loveday explores the ways our expert writers combine rigorous scientific data with empathetic and engaging content to...

Mednet

- PMLiVE

Is modular content the secret to smarter medical communications?

In her latest Ask Alex article, Principal Medical Writer, Dr Alexandra Loveday explores modular content and whether it holds the secret to smarter and more effective medical communications. As healthcare...

Mednet

- PMLiVE

J&J expands neuroscience capabilities with $14.6bn Intra-Cellular acquisition

The deal gives the company access to a range of central nervous system disorder drugs

- PMLiVE

Eli Lilly to acquire Scorpion’s solid tumour programme in deal worth $2.5bn

STX-478 is in phase 1/2 development for breast cancer and other advanced solid tumours

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links